Kymera Therapeutics, Inc.
CRBN LIGANDS AND USES THEREOF
Last updated:
Abstract:
The present invention provides compounds, compositions thereof, and methods of using the same for the inhibition of CRBN, and the treatment of CRBN-mediated disorders.
Status:
Application
Type:
Utility
Filling date:
14 Jan 2019
Issue date:
5 Nov 2020